Cargando…
Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402520/ https://www.ncbi.nlm.nih.gov/pubmed/34452034 http://dx.doi.org/10.3390/vaccines9080909 |
_version_ | 1783745809526816768 |
---|---|
author | Bohnhorst, Bettina Weidlich, Cornelia Peter, Corinna Böhne, Carolin Kattner, Evelyn Pirr, Sabine |
author_facet | Bohnhorst, Bettina Weidlich, Cornelia Peter, Corinna Böhne, Carolin Kattner, Evelyn Pirr, Sabine |
author_sort | Bohnhorst, Bettina |
collection | PubMed |
description | Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational study, preterm infants with an increase in CREs after the first rIM were monitored for CREs before and after the second rIM. Seventy-one infants with a median gestational age of 26.4 weeks and a median weight of 820 g at birth were investigated at a median postnatal age of 94 days. All but seven infants showed an increase in CREs after the second rIM. The frequency of hypoxemias (p < 0.0001), apneas (p = 0.0003) and cardiorespiratory events requiring tactile stimulation (CRE-ts) (p = 0.0034) increased significantly. The 25 infants (35%) presenting with CRE-ts were significantly more likely to have been continuously hospitalized since birth (p = 0.001) and to receive analeptic therapy at the first rIM (p = 0.002) or some kind of respiratory support at the first (p = 0.005) and second rIM (p < 0.0001). At a postmenstruational age of 43.5 weeks, CRE-ts ceased. Our data support the recommendation to monitor infants who fulfil the above-mentioned criteria during the second rIM up to a postmenstruational age of 44 weeks. |
format | Online Article Text |
id | pubmed-8402520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84025202021-08-29 Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations Bohnhorst, Bettina Weidlich, Cornelia Peter, Corinna Böhne, Carolin Kattner, Evelyn Pirr, Sabine Vaccines (Basel) Article Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational study, preterm infants with an increase in CREs after the first rIM were monitored for CREs before and after the second rIM. Seventy-one infants with a median gestational age of 26.4 weeks and a median weight of 820 g at birth were investigated at a median postnatal age of 94 days. All but seven infants showed an increase in CREs after the second rIM. The frequency of hypoxemias (p < 0.0001), apneas (p = 0.0003) and cardiorespiratory events requiring tactile stimulation (CRE-ts) (p = 0.0034) increased significantly. The 25 infants (35%) presenting with CRE-ts were significantly more likely to have been continuously hospitalized since birth (p = 0.001) and to receive analeptic therapy at the first rIM (p = 0.002) or some kind of respiratory support at the first (p = 0.005) and second rIM (p < 0.0001). At a postmenstruational age of 43.5 weeks, CRE-ts ceased. Our data support the recommendation to monitor infants who fulfil the above-mentioned criteria during the second rIM up to a postmenstruational age of 44 weeks. MDPI 2021-08-16 /pmc/articles/PMC8402520/ /pubmed/34452034 http://dx.doi.org/10.3390/vaccines9080909 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bohnhorst, Bettina Weidlich, Cornelia Peter, Corinna Böhne, Carolin Kattner, Evelyn Pirr, Sabine Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title | Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title_full | Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title_fullStr | Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title_full_unstemmed | Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title_short | Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations |
title_sort | cardiorespiratory events following the second routine immunization in preterm infants: risk assessment and monitoring recommendations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402520/ https://www.ncbi.nlm.nih.gov/pubmed/34452034 http://dx.doi.org/10.3390/vaccines9080909 |
work_keys_str_mv | AT bohnhorstbettina cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations AT weidlichcornelia cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations AT petercorinna cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations AT bohnecarolin cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations AT kattnerevelyn cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations AT pirrsabine cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations |